Submitted by Anonymous (not verified) on 6 November 2025 - 14:50
Human medicines European public assessment report (EPAR): Quadramet, samarium [153Sm] lexidronam pentasodium, Date of authorisation: 04/02/1998, Revision: 17, Status: Authorised
Source: